Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties
The chemistry of indoles. XVI. A convenient synthesis of substituted indoles carrying a hydroxy group, a halogeno group, or a carbon side chain at the 4-position via 4-indolediazonium salts and a total synthesis of (.+-.)-6,7-secoagroclavine.
[EN] LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA LYSYL OXYDASE-LIKE 2 ET UTILISATIONS DESDITS INHIBITEURS
申请人:PHARMAKEA INC
公开号:WO2016144702A1
公开(公告)日:2016-09-15
Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with LOXL2 activity.
An efficient Rh(II) carboxylate and Brønsted acid catalyzed direct π-extension of indoles to 4-substituted carbazoles is developed. The reaction involves a regioselective C-3 functionalization of indole by a rhodium enalcarbenoid and a Brønsted acid assisted cyclocondensation. In addition a twofold regioselective π-extension of pyrroles to 4,8-disubstituted carbazoles has also been developed. The utility
An easily available iron catalyst was developed to accomplish the CH functionalization of indoles with α-aryl-α-diazoesters in high yields under mild conditions. The asymmetric CH functionalization of indoles was also realized by using iron complexes of chiral spiro bisoxazolines with up to 78% ee.
Visible-light driven acetoxylation and dioxygenation of indoles <i>via</i> electron donor–acceptor complexes
作者:Aditya Paul、Arunava Sengupta、Somnath Yadav
DOI:10.1039/d3cc01683h
日期:——
photoresponsive electron donor–acceptor (EDA) complex, formed by indole and hypervalent iodine such as diacetoxyiodobenzene (DAIB/PIDA, etc.), was detectable through absorption and emission spectroscopy. Irradiation of the EDA complex with visible light triggered photoinduced singleelectrontransfer (SET) processes that were synthetically useful for the catalyst-free, regioselective acetylation of
Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with LOXL2 activity.